JP Morgan Maintains Neutral on Alignment Healthcare, Lowers Price Target to $10
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Lisa Gill maintains a Neutral rating on Alignment Healthcare (NASDAQ:ALHC) and lowers the price target from $12 to $10.
July 07, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan has maintained a Neutral rating on Alignment Healthcare and lowered the price target from $12 to $10.
The lowering of the price target by JP Morgan indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock price of Alignment Healthcare.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100